Ignite Creation Date:
2024-05-06 @ 1:30 PM
Last Modification Date:
2024-10-26 @ 1:15 PM
Study NCT ID:
NCT04040725
Status:
WITHDRAWN
Last Update Posted:
2019-12-17
First Post:
2019-07-30
Brief Title:
Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR12 Overexpression
Sponsor:
Organization:
Dana-Farber Cancer Institute